AstraZeneca Admits Its Covishield Vaccine Can Cause Rare Side Effects: Here's What They Are
SII Stopped Covishield Production In December 2021, No Takers For Booster Shots As People Are Fed Up: Poonawalla
As India Crosses 100 Crore Covid-19 Vaccinations, Here Are Four Things We Need To Realise
Bharat Biotech Calls Out ‘Covishield vs Covaxin’ Comparative Study, Adds That Report Had Lot Of Flaws
The First Quarter Billion Doses: Looking Back And Ahead
CoWIN App Reconfigured To Permit Online Bookings For 2nd Covishield Dose Only After 84 days
WHO Says B.1.617 Is Now ‘Variant of Concern’: What Do We Know So Far About Double Mutant Covid Variant
First Dose Of Oxford-Astrazeneca Covid-19 Vaccine Reduces Risk Of Death By 80 Per Cent: UK Study
Petition Filed In Bombay HC Seeking Z+ Security For SII CEO Adar Poonawalla, His Family
Govt Rubbishes Reports Claiming No New Vaccines Orders After March, Says Another 16 Crore Doses Ordered In April
As Covid-19 Cases Rise, Serum Institute Plans To Begin Overseas Production Of Covishield Vaccine: Report
US Dispatches Five Tonnes Of Oxygen Concentrators To India; More Consignments To Be Delivered Soon
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Seven More Covid-19 Vaccine Candidates In Clinical Trials: Dr Harsh Vardhan
AstraZeneca COVID-19 Vaccine Side Effects: India To Conduct Deeper Review After Suspension Of Use By Some Nations
After Trudeau’s Request, India In Principle Approves Supply Of Half-A-Million Covishield Vaccines To Canada
Pakistan To Receive ‘Made In India’ Covid19 Vaccines As Part Of Covax Global Alliance
PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: Report
Serum Institute CEO Adar Poonawalla Takes Covid Vaccine To 'Endorse' Its Safety And Efficacy
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To Government
